Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Brian Di Pace"'
2
Azithromycin versus erythromycin infusions prior to endoscopy in upper gastrointestinal bleeding
Autor: Christopher Young, Patricia A. Uber, Brian Di Pace, Adam Sima, Danny Issa, Sanjeev S. Solomon, Jonathan C. Hillyard, George Smallfield, Reem Z. Sharaiha
Publikováno v: Translational gastroenterology and hepatology, vol 7, iss 0
BackgroundIntravenous erythromycin prior to endoscopy for upper gastrointestinal bleeding (GIB) improves outcomes but requires immediate preparation delaying administration in emergency cases. Azithromycin is readily available and does not require pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f0364e4c0ad91f5a58d3fd35ea3cf4
https://escholarship.org/uc/item/8f15t1zz
Zobrazit plný text záznamu
3
AMBER parts 1c and 1e: A phase 1 study of cobolimab plus dostarlimab in patients (pts) with advanced/metastatic melanoma
Autor: Antoni Ribas, Zeynep Eroglu, Jose Manuel Manuel Trigo Perez, Brian Di Pace, Tianli Wang, Srimoyee Ghosh, Arindam Dhar, Theo Borgovan, Angela Waszak, Diwakar Davar
Publikováno v: Journal of Clinical Oncology. 40:9513-9513
9513 Background: TIM-3 and PD-1 are markers of T-cell suppression that are upregulated in melanoma. AMBER (NCT02817633) is evaluating cobolimab (TSR-022/GSK4069889), an anti-TIM-3 therapy, monotherapy or with PD-1 inhibitors, including dostarlimab, i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c66d9012e70ee5f77d1ca129288b4381
https://doi.org/10.1200/jco.2022.40.16_suppl.9513
Zobrazit plný text záznamu
4
Phase 1 trial of TIM-3 inhibitor cobolimab monotherapy and in combination with PD-1 inhibitors nivolumab or dostarlimab (AMBER)
Autor: Gerald Steven Falchook, Antoni Ribas, Diwakar Davar, Zeynep Eroglu, Judy S. Wang, Jason J. Luke, Erika P. Hamilton, Brian Di Pace, Tianli Wang, Srimoyee Ghosh, Arindam Dhar, Theo Borgovan, Angela Waszak, Patricia LoRusso
Publikováno v: Journal of Clinical Oncology. 40:2504-2504
2504 Background: TIM-3 expressed on tumor-infiltrating T cells is associated with T-cell suppression. AMBER (NCT02817633) is evaluating cobolimab (TSR-022/GSK4069889) monotherapy and with PD-1 inhibitors in advanced solid tumors. Methods: Multi-cente
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c2ad4db78f97c3caf7bd76440bd59717
https://doi.org/10.1200/jco.2022.40.16_suppl.2504
Zobrazit plný text záznamu
5
Azithromycin Versus Erythromycin Infusions in Upper Gastrointestinal Bleeding
Autor: Brian Di Pace, Danny Issa, Adam Sima, Christopher Young, Sanjeev S. Solomon, Jonathan C. Hillyard, George Smallfield, Reem Z. Sharaiha, Patricia A. Uber
Publikováno v: SSRN Electronic Journal.
Background: Intravenous erythromycin prior to endoscopy for upper gastrointestinal bleeding (GIB) improves outcomes but requires immediate preparation delaying administration in emergency cases. Azithromycin is readily available and does not require
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2299e53531e1cc7fdae9243e794955a6
https://doi.org/10.2139/ssrn.3339497
Zobrazit plný text záznamu
6
Towards Predicting Graft Vs Host Disease from Predicted Tissue Specific Minor Histocompatibility Antigens
Autor: Max Jameson-Lee, Gregory A. Buck, Brian Di Pace, Vishal N. Koparde, Kang Le, Amir A. Toor, Michael C. Neale, Erin Donahue, Cathy Roberts
Publikováno v: Blood. 132:3395-3395
Graft versus host disease (GVHD) continues to be a life-threatening complication of stem cell transplantation for hematological malignancies. GVHD occurs in perfectly HLA-matched, related (MRD) transplants, and conversely can be absent in matched un-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c00d8190f787278c4735e2339e9d1ac
https://doi.org/10.1182/blood-2018-99-119783
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje